In this regard, BMPR2 overexpression has also been reported in the peripheral blood of patients with advanced breast cancer, possibly reflecting altered systemic signaling or a compensatory mechanism with potential diagnostic value.8 Here, BMPR2 is linked to breast carcinoma.